Rachida Lebtahi

Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs

Dik J. Kwekkeboom, Eric P. Krenning, Rachida Lebtahi et al. · Neuroendocrinology · 2009 · 349 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.

Rachida Lebtahi, Guillaume Cadiot, Doumit Daou et al. · PubMed · 1997 · 242 citations

Medicine, Nuclear Medicine, Oncology +17

Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy

Jean‐Baptiste Cavin, Anne Couvelard, Rachida Lebtahi et al. · Gastroenterology · 2015 · 209 citations

Medicine, Endocrinology, Surgery +14